Moreover, the amplification of the chromosome 17q23 and chromosome 6p21 regions has been shown to cause the overexpression of SRSF1 in breast cancer and SRSF3 in lung and cervical carcinoma, respectively (Parssinen et al., 2007; Jia et al., 2010). This evidence concerns the gene SRSF1 and breast carcinoma.